Prothena focuses on the development of novel protein immunotherapies for the treatment of cell adhesion.
Business Model:
Revenue: $65.8M
Employees: 51-200
Address: 77 Sir John Rogerson’s Quay
City: Dublin
State: county dublin
Zip:
Country: IE
Prothena focuses on the development of novel protein immunotherapies for the treatment of cell adhesion.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
12/28/2012
Ticker Symbol:
PRTA
Amount Raised:
$122M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2017 | Post-IPO Equity | $155.3M | 5/2021 | Post-IPO Equity | $60M | 12/2012 | IPO | $122.1M | 1/2013 | Post-IPO Equity | 1 | - |
Sofinnova Investments Sofinnova Investments |
12/2022 | Post-IPO Equity | $172.4M | 3/2021 | Post-IPO Equity | $67.8M | 3/2018 | Post-IPO Equity | $50M | 1/2013 | Post-IPO Equity | 1 | - |
Sofinnova Investments Sofinnova Investments |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|